clinical trial · NCT00092729
An Investigational Drug Study in the Treatment of Primary Dysmenorrhea (0663-064)
Organon and Co·phase3·completed·n = 129
Dysmenorrheaetoricoxib (MK0663)Comparator: placebo (unspecified)Comparator: naproxen sodium
brief summary
The purpose of this study is to evaluate the pain relieving effect and safety of an investigational drug in women with moderate to severe primary dysmenorrhea (painful menstruation).
started
Jun 7, 2002
primary completion
Dec 6, 2002
completion
Dec 6, 2002
last updated
Aug 15, 2024
official title
A Randomized, Placebo-and Active-Comparator-Controlled Study of Etoricoxib 120 mg in the Treatment of Primary Dysmenorrhea
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol